This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. From late 2020 to the summer of 2024, Eli Lilly & Co.

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and ...

Eli Lilly (LLY) shares clocked seven straight sessions of losses on Friday, as the stock was 0.5% lower at $1,009.15. The pharmaceutical giant lost 8% in the preceding six sessions. Overall, the stock ...

Day 1. We're thrilled today to -- my name is Geoff Meacham. I'm the senior biopharma analyst, and my team is in the audience as well. So we're thrilled today to have Ilya Yuffa, who is EVP and ...

It seems like every few weeks, there’s a new “miracle fix” for anxiety trending on social media. The latest is a decades-old heart medication that more and more people are saying helps them stay calm ...

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The ...

Len Yaffee says Eli Lilly stock will find it hard to push any higher from here. The Kassef Capital's chief executive explained why in a recent CNBC interview. LLY shares are already up a whopping 75% ...